Inventor · disambiguated record
Yun Lu
Also filed as: LU YUN · LU YUN MARTIN
14 granted patents·4 pending applications·18 citations·filing 2015–2024
86Inventor score
Top patents by PatentIndex Score
18 records- 0193US12163015B2Thermoplastic elastomer compositionGEON PERFORMANCE SOLUTIONS LLC·Filed 2022·Granted Dec 10, 2024·1 cites·22 claims
- 0290US11447619B2Thermoplastic elastomer compositionPolymax TPE LLC·Filed 2020·Granted Sep 20, 2022·3 cites·24 claims
- 0387US2024409729A1Thermoplastic elastomer compositionGEON PERFORMANCE SOLUTIONS LLC·Filed 2024·Application pending·0 cites
- 0485US10786507B2Pharmaceutical composition containing JAK kinase inhibitor or pharmaceutically acceptable salt thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Sep 29, 2020·11 cites·12 claims
- 0575US10626116B2Crystalline form of BTK kinase inhibitor and preparation method thereofJIANGSU HENGRUI MEDICINE CO·Filed 2016·Granted Apr 21, 2020·2 cites·11 claims
- 0674US10722469B2Method for preparing pharmaceutical composition comprising quinoline derivative or salt thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Jul 28, 2020·1 cites·4 claims
- 0764US2023265268A1Thermoplastic elastomer compositionPolymax TPE LLC·Filed 2023·Application pending·0 cites
- 0854US11065241B2Pharmaceutical composition comprising quinoline derivative or salt thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Jul 20, 2021·0 cites·19 claims
- 0953US10588978B2Pharmaceutical composition containing imidazoline derivativeJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Mar 17, 2020·0 cites·19 claims
- 1052US11059810B2Pharmaceutically acceptable salt as renal outer medullary potassium channel inhibitorJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Jul 13, 2021·0 cites·6 claims
- 1146US10150739B2Crystalline form of androgen receptor inhibitor and preparation method thereofJIANGSU HENGRUI MEDICINE CO·Filed 2016·Granted Dec 11, 2018·0 cites·16 claims
- 1243US2019070181A1Formulation of ticagrelor or pharmaceutically acceptable salt thereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Application pending·0 cites
- 1342US10973807B2Pharmaceutical composition comprising pyrrolo-fused six-membered heterocyclic compoundJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Apr 13, 2021·0 cites·10 claims
- 1442US10301344B2L-proline complex of sodium-glucose cotransporter 2 inhibitor, monohydrate and crystal form thereofJIANGSU HENGRUI MEDICINE CO·Filed 2015·Granted May 28, 2019·0 cites·17 claims
- 1542US2020347039A1Crystal form of renal outer medullary potassium channel inhibitor and preparation method thereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Application pending·0 cites
- 1640US10258584B2Pregabalin sustained-release preparationJIANGSU HENGRUI MEDICINE CO·Filed 2015·Granted Apr 16, 2019·0 cites·20 claims
- 1737US11116752B2Pharmaceutical composition comprising bicyclo-substituted pyrazolon azo derivative or salt thereof and preparation method thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Sep 14, 2021·0 cites·14 claims
- 1834US10966964B2Method for preparing pharmaceutical composition comprising pyrrolo-fused six-membered heterocyclic compoundJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Apr 6, 2021·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Yun Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →